Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-
 
WKN: 886715 / Name: AstraZeneca / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Astrazeneca ADR Stock

Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Astrazeneca ADR stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Astrazeneca ADR in the next few years

Pros
?
M***** P*******
?
B****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Astrazeneca ADR vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Astrazeneca ADR - - - - - - -
GSK plc ADR -2.000% -5.385% 10.314% 35.165% 17.703% 50.000% 38.592%
Bayer AG ADR -1.070% -0.971% -7.273% 74.359% 15.909% -28.169% -20.313%
UCB S.A. 4.590% -7.695% -3.762% 32.856% 5.602% 212.282% 211.274%

News

As Investors Flee U.S. Equities, This Global ETF Is Outperforming
As Investors Flee U.S. Equities, This Global ETF Is Outperforming

Since the start of the year, investors have been vacating U.S. stocks and exchange-traded funds (ETFs) in a broad-based, risk-off strategy that has benefited safe-haven assets like gold and silver

After a Near 50% Drop, Tempus AI Could Be Ripe for a Rebound
After a Near 50% Drop, Tempus AI Could Be Ripe for a Rebound

Since going public in mid-2024, shares of healthcare and life science services company Tempus AI (NASDAQ: TEM) have gone on a wild rollercoaster ride. The firm’s initial public offering price

A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH

More than just a financial check-up, earnings for companies in the healthcare sector offer a key window for investors into a firm's pipeline and development progress. Even well-established, stable